← SynDRA
ONATASERTIB
SynDRA canonical compound SYN0038323 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | MTOR |
|---|
| Mechanism of action | mTOR inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MTOR inhibitor
- MTOR MODULATOR
Cross-references
Synonyms
- CC-223
- ATG-008
- ATG008
- CC223
- GW-791343 hydrochloride
- GW791343 trihydrochloride
- GW791343 HCl
- GW791343 (trihydrochloride)
- GW791343
- GW-791343
- 2-[(3,4-Difluorophenyl)amino]-N-[2-methyl-5-(1-piperazinylmethyl)phenyl]-acetamide trihydrochloride
- GW791343 (HCL)
- C20H27Cl3F2N4O
- GW 791343 Trihydrochloride
- C20H24F2N4O.3ClH
- CTK8F0044
- EX-A438
- GW 791343 HCl
- WSBRAHWNJBXXJM-UHFFFAOYSA-N
- MolPort-023-219-209
- BCP23425
- AKOS024457596
- CS-1030
- BCP9000749
- API0008007
- HY-15470
- BCP0726000290
- RT-017402
- KB-272661
Look up ONATASERTIB in the interactive SynDRA portal →